
Contributions by role
Contributions by subject area
Lalit Batra
Summary
Dr. Lalit Batra is a Research Scientist within the Center for Predictive Medicine at the University of Louisville.
His research interests/output includes:
- Evaluation of efficacy Q-Griffithsin and AS1411 against SARS-CoV2 infection in hamsters, ferrets and hACE2 mice.
- Cancer Immunoprevention using a novel CD137 receptor agonist SA-4-1BBL molecule.
- Evaluated and published the role of novel SA-4-1BBL molecule as stand-alone monotherapeutics agent for Cancer Immunoprevention against TC-1, huMUC-1 and 3LL mouse tumor models.
- Evaluating the monotherapeutic role of SA-4-1BBL molecule against variety of tumor models such as melanoma, lymphoma, breast cancer and spontaneous cancer models.
- Vaccine approaches using SA-4-1BBL molecule against Yersinia pestis Infection (ABSL3).
- Evaluated and published the role of SA-4-1BBL as an adjuvant with the lead Y. pestis antigen (rF1-V) against lethal pneumonic plague challenge in BALB/c and C57BL/6 mice.
- Development of immunomodulatory protocols for overcoming allograft rejection for Type I Diabetes Mellitus (T1D).
- Evaluated and published the efficacy of immunomodulatory molecules such as SA-PDL1, SA-FasL and SA-CD47 for prevention of allograft rejection in chemically diabetic Mouse models.
- Evaluating the efficacy of SA-FasL for reversal of diabetes in recent-onset NOD mice.
Agricultural Science Allergy & Clinical Immunology Biotechnology Cell Biology Clinical Trials COVID-19 Diabetes & Endocrinology Epidemiology Food Science & Technology Gastroenterology & Hepatology Genetics Genomics Healthcare Services Hematology Histology Immunology Infectious Diseases Mental Health Microbiology Molecular Biology Parasitology Pharmacology Plant Science Public Health Translational Medicine Tuberculosis Veterinary Medicine Virology Zoology